港股異動丨信義玻璃(0868.HK)急升超6%再度破頂 本月初獲多位董事共增持569.8萬股
格隆匯9月16日丨信義玻璃(0868.HK)尾盤急升至6.23%再次創下新高,報15港元,暫成交1.7億港元,最新總市值605.3億港元。公司股價自5月底以來持續上漲,累計漲幅超90%,近日更是加速上漲,4日漲近12%續創歷史新高。信義玻璃本月初獲多位董事合共增持569.8萬股,涉資7602萬港元。增持股價處於高位,可見管理層看好公司發展前景。此前公佈的中報顯示,中期純利減少34.9%至13.82億港元,中期息17港仙,但績後獲多家大行唱好,稱業績符合預期,並看好下半年行情回暖。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.